Clinical trials
Phase 2 Lung Neoplasms trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Vestre Viken Hospital Trust | 2 |
| Boehringer Ingelheim | 1 |
| Daiichi Sankyo | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Oslo University Hospital | 1 |
| Åslaug Helland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Adenocarcinoma of Lung | 3 |
| Melanoma | 2 |
| Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
| Mesothelioma | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.